Clinical Trial

Cognitive Stimulation for Elderly Bipolar Patients

Study acronym: TONIC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2025 (before its estimated March 3, 2026 completion). Its status may not reflect the trial's current state.
Summary
Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to exist, and alterations increase significantly after the age of 65. Drug treatments seem to have only a limited effect. A cognitive stimulation program has proven his benefit to patients over 65 with neurodegenerative diseases (Israel, 2004). We propose to evaluate this cognitive stimulation program that we have adapted to bipolar disease.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2019-11-29; most recent amendment 2025-03-13.
Status change: Not Yet Recruiting → Recruiting 2020-09-17
Trial Details
NCT Number NCT04184375
Lead Sponsor Groupe Hospitalier de la Rochelle Ré Aunis
Conditions Bipolar Disorder, Cognitive Impairment, Age-related Cognitive Decline
Enrollment 40 participants
Start Date 2021-03-04
Primary Completion 2026-03-03 (estimated)
Study Completion 2026-09-03 (estimated)
Updated on ClinicalTrials.gov 2025-03-17